Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Amyloid is a brain protein which is associated with dementia, but it is difficult and expensive to detect. This team is conducting brain scans on 500 men and women who are already members of a long-term health study. Their extremely valuable data will be used to develop new, more convenient ways of testing for amyloid in the brain.

Amyloid negative and positive pet scans
Simultaneous PET-MR scanning is new and advanced technique allowing scientists to see inside the brain at very fine detail.

The team is using an advanced brain scanning technique – PET-MR imaging – on 500 people who are members of the 1946 birth cohort. The scans will help scientists develop convenient and robust methods to identify cases of dementia, Parkinson's disease or Motor Neurone disease from the data that is routinely gathered by long-term health studies, GPs, hospitals and death records. These recently completed brain scans makes these participants' data extremely valuable for further research.

 

Selected publications